VSTM VERASTEM INC

Ownership history in ORBIMED ADVISORS LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in VERASTEM INC (VSTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.41% (2025 Q1)
Avg. % of fund
0.24%
First filed
2023 Q2
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 887,561 -1,974,887 -69.0% 0.18% $7.8M $8.83
2025 Q1 UNCHANGED 2,862,448 0% 0.41% $17.3M $6.03
2024 Q4 UNCHANGED 2,862,448 0% 0.30% $14.8M $5.17
2024 Q3 ADDED 2,862,448 +1,333,333 +87.2% 0.16% $8.6M $2.99
2024 Q2 UNCHANGED 1,529,115 0% 0.09% $4.6M $2.98
2024 Q1 UNCHANGED 1,529,115 0% 0.33% $18.0M $11.80
2023 Q4 UNCHANGED 1,529,115 0% 0.25% $12.4M $8.14
2023 Q3 UNCHANGED 1,529,115 0% 0.26% $12.4M $8.13
2023 Q2 INITIATED 1,529,115 0.21% $11.4M $7.44
% of Fund (quarterly)    VSTM price (monthly, adj. close)
← Back to ORBIMED ADVISORS LLC Holdings